Literature DB >> 646392

Psoralen-UVA-treated psoriatic lesions. Ultrastructural changes.

K Hashimoto, H Kohda, M Kumakiri, S L Blender, I Willis.   

Abstract

Psoralen-ultraviolet light (PUVA)-treated psoriatic lesions were studied for ultrastructural changes. In early stages of treatment, sunburn cells in the epidermis and bizarre giant cells in the dermis were more frequently observed. When clinical improvement was apparent, these changes had subsided. Dermal abnormality in long-term therapy consisted of a thick perivascular coat of amorphous substance. No abnormality was found in the epidermal keratinocytes in long-term therapy, except a clustering and giant cell formation of melanocytes, a heavy melanization of keratinocytes, and hyperkeratosis. Low-dose initiation and slow increment of both 8-methoxypsoralen and UVA is probably a reasonable regimen for benign dermatoses such as psoriasis because it will allow enough time for the skin to become more protected, while the therapeutic results are as satisfactory as in a high-dose schedule.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646392

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  Dermal dendrocytes and photochemotherapy.

Authors:  G E Piérard; A Nikkels; J Arrese Estrada; T Ben Mosbah; C Piérard-Franchimont
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  A semiquantitative light and electron microscopic analysis of histopathologic changes in photochemotherapy-induced freckles.

Authors:  L Kanerva; K M Niemi; J Lauharanta
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

3.  Fine structure of Merkel cells after PUVA treatment.

Authors:  L Kanerva; K M Niemi; J Lauharanta; A Lassus
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

4.  Regenerated cutaneous nerves in human epidermal and subepidermal regions. An electron microscopy study.

Authors:  M Mihara
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.